Glycobia, Inc.
Pharmaceutical company · Ithaca, New York, United States
Glycobia, Inc. is a pharmaceutical company headquartered in Ithaca, New York, United States. Its earliest recorded incorporation is in 2008. It has received 14 US government small-business research awards (SBIR/STTR) from health agencies, $7.3 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2010.
Glycobia at a glance
What does Glycobia do?
US government research funding
14 SBIR/STTR small-business research awards from US health agencies, $7.3 million in total (2009 to 2019). NIH funding came from the National Institute of General Medical Sciences, National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $500,000 sold (2010).
Frequently asked questions about Glycobia
Where is Glycobia headquartered?
Glycobia, Inc. is headquartered in Ithaca, New York, United States.
What does Glycobia do?
Glycobia, Inc. is a pharmaceutical company.
When was Glycobia founded?
The earliest incorporation on record for Glycobia, Inc. is in 2008, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences